These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20304521)

  • 1. [Treatment of glaucoma in patients with dry eye syndrome].
    Labbé A; Baudouin C
    J Fr Ophtalmol; 2010 Apr; 33(4):285-90. PubMed ID: 20304521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of failure in glaucoma filtering surgery: a consequence of antiglaucomatous drugs?
    Baudouin C
    Int J Clin Pharmacol Res; 1996; 16(1):29-41. PubMed ID: 9001927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Challenge and treatment strategy for ocular surface damage in patients with long term use of antiglaucoma drugs].
    He XG
    Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):101-4. PubMed ID: 21426837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in preservative-free glaucoma drops].
    Stefan C; Pop A; Cojocaru I
    Oftalmologia; 2011; 55(2):3-6. PubMed ID: 21888063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glaucoma and ocular surface].
    Stefan C; Cojocaru I; Pop A
    Oftalmologia; 2011; 55(1):30-3. PubMed ID: 21774383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser therapies for glaucoma: new frontiers.
    Scuderi GL; Pasquale N
    Prog Brain Res; 2008; 173():225-36. PubMed ID: 18929112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma.
    Baudouin C
    Acta Ophthalmol; 2008 Nov; 86(7):716-26. PubMed ID: 18537937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of ocular surface disease in glaucoma patients.
    Leung EW; Medeiros FA; Weinreb RN
    J Glaucoma; 2008 Aug; 17(5):350-5. PubMed ID: 18703943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
    Sonty S; Mundorf TK; Stewart JA; Stewart WC
    Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical analysis of corticosteroid ocular hypertension and corticosteroid glaucoma after photorefractive keratectomy].
    Li C; Zhang J; Huang C
    Zhonghua Yan Ke Za Zhi; 1999 May; 35(3):179-82. PubMed ID: 11835800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular surface damage by ophthalmic compounds.
    Mantelli F; Tranchina L; Lambiase A; Bonini S
    Curr Opin Allergy Clin Immunol; 2011 Oct; 11(5):464-70. PubMed ID: 21822131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of eye drop administration technique in patients with glaucoma or ocular hypertension.
    Schwartz GF; Hollander DA; Williams JM
    Curr Med Res Opin; 2013 Nov; 29(11):1515-22. PubMed ID: 24006861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma.
    Nagar M; Ogunyomade A; O'Brart DP; Howes F; Marshall J
    Br J Ophthalmol; 2005 Nov; 89(11):1413-7. PubMed ID: 16234442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A National Survey of Glaucoma Specialists on the Preoperative (Trabeculectomy) Management of the Ocular Surface (.).
    Tailor R; Batra R; Mohamed S
    Semin Ophthalmol; 2016; 31(6):519-25. PubMed ID: 25489986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Managing treatment side effects: the respective roles of the active ingredient and the preservative].
    Aptel F; Denis P; Baudouin C
    J Fr Ophtalmol; 2011 Jun; 34(6):409-12. PubMed ID: 21511364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The impact of trabeculectomy on ocular surface].
    Li LX; Liu W; Ji J
    Zhonghua Yan Ke Za Zhi; 2013 Feb; 49(2):185-8. PubMed ID: 23714036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laser correction of recurrence of increased intraocular pressure after surgical valvular sinuso-trabeculectomy].
    Kurdagli N; Mamedov NG; Novoderezhkin VV
    Vestn Oftalmol; 1992; 108(3):8-10. PubMed ID: 1481338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dry eye specific quality of life in veterans using glaucoma drops.
    Camp A; Wellik SR; Tzu JH; Feuer W; Arheart KL; Sastry A; Galor A
    Cont Lens Anterior Eye; 2015 Jun; 38(3):220-5. PubMed ID: 25737401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pressure reduction after selective laser trabeculoplasty with two different laser systems and after argon laser trabeculoplasty--a controlled prospective clinical trial on 284 eyes].
    Best UP; Domack H; Schmidt V
    Klin Monbl Augenheilkd; 2007 Mar; 224(3):173-9. PubMed ID: 17385117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.